Skip to main content

Table 6 Distribution of recurrent cardiac ischemic events by non-genetic factors

From: The frequencies of CYP2C19*2, *3, and *17 alleles and their impact on the clinical efficacy of doubled maintenance dose of clopidogrel in Syrian patients with coronary artery disease

Variables

Refractory angina symptoms

P value

Major adverse cardiac events

P value

Yes

No

Yes

No

Gender

Male

4 (14.81%)

23 (85.19%)

> 0.9999

0 (0%)

27 (100%)

0.1228

Female

2 (14.28%)

12 (85.71%)

2 (14.28%)

12 (85.71%)

BMI

Normal

1 (7.69%)

12 (92.31%)

0.19134

0 (0%)

13 (100%)

0.1317

Overweight

1 (7.14%)

13 (92.86%)

0 (0%)

14 (100%)

Obese

4 (28.57%)

10 (71.42%)

2 (14.28%)

12 (85.72%)

Hypertension

Yes

4 (12.90%)

27 (87.10%)

0.6221

1 (4.76%)

20 (95.24%)

> 0.9999

No

2 (10%)

18 (90%)

1 (5%)

19 (95%)

Diabetes

Yes

3 (27.27%)

8 (72.73%)

0.3162

1 (9.1%)

10 (90.9%)

0.4695

No

3 (10%)

27 (90%)

1 (3.33%)

29 (96.77%)

Proton Pump Inhibitor Use

Yes

4 (18.18%)

18 (81.82%)

0.6681

0 (0%)

22 (100%)

0.2085

No

2 (10.52%)

17 (89.47%)

2 (10.53%)

17 (89.47%)

Calcium Chanel Blockers Use

Yes

3 (30%)

7 (70%)

0.1435

0 (0%)

10 (100%)

> 0.9999

No

3 (9.67%)

28 (90.33%)

2 (6.45%)

29 (93.55%)